secwatch.observer — SEC 8-K summary
======================================

Issuer:     SQZ Biotechnologies Co (—)
CIK:        0001604477
Form:       8-K
Filed at:   2023-07-03T23:59:59+00:00
Accession:  0000950170-23-031345
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

SQZ Biotechnologies receives NYSE delisting notice; reverse split deferred
--------------------------------------------------------------------------

- NYSE notified SQZ on July 3 of delisting for average global market cap below $15M over 30 trading days.
- Company will not appeal; trading suspended after July 3 close. Stock begins OTC trading on July 5.
- OTC markets may offer less liquidity and could further depress stock price; no assurance of continued trading.
- Reverse stock split, previously set for July 6, deferred to an undetermined later date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604477/000095017023031345/0000950170-23-031345-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604477/000095017023031345/sqz-20230703.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-031345

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer